Effects of 17β-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro

Cardiovascular Research

Volumn 32, Issue 3, 1996, Pages 516-523

  Suzuki, Akihiko ^a   Mizuno, Kimio ^a   Ino, Yasushi ^a   Okada, Mayumi ^a   Kikkawa, Fumitaka ^a   Mizutani, Shigehiko ^a   Tomoda, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Estrogen; Growth factors; Human; Postmenopausal hormone replacement therapy; Progestin; Smooth muscle cell; Smooth muscle cell proliferation

Indexed keywords

ANTIESTROGEN; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTRIOL; ESTROGEN RECEPTOR; ESTRONE; PLATELET DERIVED GROWTH FACTOR BB; PROGESTERONE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MENOPAUSE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ADULT; AORTA; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROGESTERONE; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; TAMOXIFEN;

EID: 0030245551     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00105-8     Document Type: Article

References (45)

1. [1] Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954-963.
2. [2] Sullivan JM, Vander Zwaag R, Lemp GF, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988;108:358-363.
3. [3] Barret-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991;265:1861-1867.
4. [4] The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc 1995;273:199-208.
5. [5] Walsh BW, Schiff I, Roster B, Greenberg L. Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204.
6. [6] Kushiwaha RS. Female sex steroid hormones and lipoprotein metabolism. Curr Opin Lipidol 1992;3:167-172.
7. [7] Tikkanen MJ. Role of lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects. Am J Obstet Gynecol 1990;163:296-304.
8. [8] Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:89-104.
9. [9] Ross R, Glomset JA. Atherosclerosis and arterial smooth muscle cell: proliferation of smooth muscle cell is a key event in the genesis of the lesion of atherosclerosis. Science 1973;180:1332-1339.
10. [10] Stumpf WE, Sar M, Aumuller G. The heart: a target organ for estradiol. Science 1977;196:319-321.
11. [11] Lin LA, McGill HC, Shain SA. Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Circ Res 1982;50:610-616.
12. [12] Lin LA, Gonzalez R, Carey KD, Shain SA. Estradiol-17β affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis 1986;6:495-504.
13. [13] Lin LA, Shain SA. Sexual dimorphism characterizes steroid hormone modulation of rat aortic hormone receptors. Endocrinology 1986;119:296-302.
14. [14] Orimo A, Inoue S, Ikegami A, et al. Vascular smooth muscle cells as a target for estrogen. Biochem Biophys Res Commun 1993;195:730-736.
15. [15] Ross R. The pathogenesis of atherosclerosis. N Engl J Med 1986;314:488-500.
16. [16] Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J Biol Chem 1992;267:22806-22812.
17. [17] Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-esradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1987;244:19-22.
18. [18] Magness RR, Rosenfeld CR, Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol 1989;256:E536-E542.
19. [19] Jiang C, Sarrel PM, Lindsay DC. Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991;104:1033-1037.
20. [20] Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile response to endothelin-1. Am J Physiol 1992;263:H271-H275.
21. [21] Cheng DY, Gruetter CA. Chronic estrogen alters responsiveness to angiotensin II and norepinephrine in female rat aorta. Eur J Pharmacol 1992;215:171-176.
22. [22] Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term admnistration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452-457.
23. [23] Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res 1993;27:1939-1942.
24. [24] Fischer-Dzoga K, Wissler RW, Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol 1983;39:355-363.
25. [25] Vargas R, Wroblewska B, Rego A, Hatch J. Ramwell PW. Oestradol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993;109:612-617.
26. [26] Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol 1992;211:163-167.
27. [27] Adams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051-1057.
28. [28] Beldekas JC, Smith B, Gerstenfeld LC, Sonesheinm GE, Franzblau C. Effect of 17β-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry 1981;20:2162-2167.
29. [29] Fisher GM, Swain ML. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aorta. Atherosclerosis 1985;54:177-185.
30. [30] Miller H, Williams MA. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991;261:R1022-R1027.
31. [31] Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
32. [32] Hashimoto M, Nakamura T, Inoue S, et al. Follistatin is a developmentally regulated cytokine in neural differentiation. J Biol Chem 1992;267:7203-7206.
33. [33] Koike S, Sasaki M, Muramatsu M. Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res 1987;15:2499-2513.
34. [34] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
35. 51Cr-labeled polymorphonuclear leukocytes. J Immunol Methods 1989;120:125-131.
36. [36] Jordan VC. Biochemical pharmacology of antiestrogen action. Pharmacol Rev 1984;36:245-257.
37. [37] Green S, Walter P, Kumar V, et al. Human oestrogen receptor cDNA; sequence, expression and homology to v-erb-A. Nature 1986;320:134-139.
38. [38] Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-1950.
39. [39] Ingar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA. Peptide growth factors elicit estrogen-receptor dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 1993;7:992-998.
40. [40] Biro S, Fu Y-M, Yu Z-X, Epstein SE. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Pro Natl Acad Sci USA 1993;90:645-648.
41. [41] Moyer DL, de Lignieres B, Driguez P, Pez JP. Prevention of endometrial hyperplasia by progesterone during long-term estrogen replacement: influence of bleeding pattern and secretary changes. Fertil Steril 1993;59:992-997.
42. [42] Proug SG, Aksel S, Wiebe RH, Shepherd J. Continuous estrogen/progestin therapy in menopause. Am J Obstet Gynecol 1987;157:1449-1453.
43. [43] Lin AL, McGill HC, Shain SA. Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Circ Res 1982;50:610-616.
44. [44] Ingegno MD, Money SR, Thelmo W. et al. Progesterone receptors in the human heart and great vessels. Lab Invest 1988;59:353-356.
45. [45] Nishigaki I, Sasaragi Y, Yagi K. Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta. Atherosclerosis 1995;113:167-170.